ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 126849 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 126849; 2) Community: the network communities that were significantly associated with the response to NSC 126849; 3) Molecule: the relationships between components within communities and NSC 126849; 4) MDR: the compounds that were significantly associated with the NSC 126849.

NSC Compound Enrichment Correlation
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.00841144976667934 0.50891903
NSC 718781 Erlotinib hydrochloride 0.00841144976667934 -0.17551059
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.00841144976667934 0.33684664
NSC 726217 Combretastatin A4-analogue 0.00841144976667934 0.38720675
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.00841144976667934 0.35663141
NSC 743532 Null 0.00841144976667934 0.28112382
NSC 135929 Null 0.00888636978630776 0.37135913
NSC 194124 Piperidinium, 1,1-didodecyl-3-methyl-, bromide 0.00888636978630776 0.32429231
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.00888636978630776 0.53257674
NSC 405640 Tin, diphenyl-, dichloride 0.00888636978630776 0.29431909
Total:154  Current:53    [First] [Prev] [Next] [Last]